Arden Trust CO Biomarin Pharmaceutical Inc Transaction History

Arden Trust CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 11, 2022	SELL	$74.28 - $92.69 $283,303 - $353,519	-3,814 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$71.72 - $91.47 $3,514 - $4,482	-49 Reduced 1.27%	3,814 $337,000
Q3 2021 Oct 12, 2021	SELL	$74.77 - $85.47 $11,963 - $13,675	-160 Reduced 3.98%	3,863 $299,000
Q2 2021 Jul 19, 2021	SELL	$75.51 - $84.79 $24,314 - $27,302	-322 Reduced 7.41%	4,023 $335,000
Q1 2021 Apr 23, 2021	SELL	$74.73 - $90.69 $55,673 - $67,564	-745 Reduced 14.64%	4,345 $328,000
Q4 2020 Jan 15, 2021	SELL	$72.61 - $90.2 $23,235 - $28,864	-320 Reduced 5.91%	5,090 $446,000
Q3 2020 Oct 15, 2020	SELL	$71.87 - $131.03 $111,039 - $202,441	-1,545 Reduced 22.21%	5,410 $412,000
Q2 2020 Jul 09, 2020	SELL	$79.55 - $124.22 $132,768 - $207,323	-1,669 Reduced 19.35%	6,955 $857,000
Q1 2020 Apr 16, 2020	BUY	$71.37 - $96.85 $128,323 - $174,136	1,798 Added 26.34%	8,624 $729,000
Q4 2019 Jan 17, 2020	SELL	$64.27 - $86.37 $29,178 - $39,211	-454 Reduced 6.24%	6,826 $577,000
Q3 2019 Oct 09, 2019	BUY	$67.4 - $85.11 $20,826 - $26,298	309 Added 4.43%	7,280 $491,000
Q2 2019 Jul 23, 2019	BUY	$80.35 - $93.9 $560,119 - $654,576	6,971 New	6,971 $597,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.